Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00704171 · ClinicalTrials.gov registry record · Phase 4
PleuraSeal Post Market Study (Europe)
A Phase 4 study, sponsored by Integra LifeSciences Corporation.
- Completed
- Registry status
- Phase 4
- Development phase
- 121
- Enrollment target
NCT00704171 is a Phase 4 study that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 121 participants.
The verdict
NCT00704171, a Phase 4 study, has completed, sponsored by Integra LifeSciences Corporation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 121 participants
- Enrollment target
Study Summary
To further characterize the PleuraSeal Sealant System as compared to standard of care (sutures and staples only) in subjects undergoing an elective pulmonary lobectomy and segmentectomy via open thoractomy.
Interventions
- PROCEDURE Standard Tissue Closure Techniques
- DEVICE PleuraSeal Lung Sealant System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00704171
The ClinicalTrials.gov registry entry for NCT00704171 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Tissue Closure Techniques is the first listed.
NCT00704171 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00704171 about?
NCT00704171 is a clinical study titled "PleuraSeal Post Market Study (Europe)". To further characterize the PleuraSeal Sealant System as compared to standard of care (sutures and staples only) in subjects undergoing an elective pulmonary lobectomy and segmentectomy via open thoractomy.
What is the current status of trial NCT00704171?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 121 participants. The study started on 2008-01. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00704171?
The interventions under investigation include: Standard Tissue Closure Techniques (PROCEDURE), PleuraSeal Lung Sealant System (DEVICE).
Who is sponsoring clinical trial NCT00704171?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.